Neal Walker, President and CEO

ACRS 917,345 shares

The estimated Net Worth of Neal Walker is at least $6,384,721.20. Neal Walker owns over 917,345 units of Aclaris Therapeutics, Inc. stock worth over $6,384,721.20.

Transaction DateCompanySharesTypeOwnedPriceValuePost Value
1st February 2019ACRS - Aclaris Therapeutics, Inc.3,579Payment by withholding917,345$6.96$24,909.84$6,384,721.20
1st February 2019ACRS - Aclaris Therapeutics, Inc.10,800Exercise of derivative920,924$0.00
16th December 2019ACRS - Aclaris Therapeutics, Inc.782Payment by withholding919,596$1.80$1,407.60$1,655,272.80
16th December 2019ACRS - Aclaris Therapeutics, Inc.3,033Exercise of derivative920,378$0.00
18th December 2019ACRS - Aclaris Therapeutics, Inc.743Payment by withholding921,778$1.81$1,344.83$1,668,418.18
18th December 2019ACRS - Aclaris Therapeutics, Inc.2,925Exercise of derivative922,521$0.00
3rd February 2020ACRS - Aclaris Therapeutics, Inc.3,675Payment by withholding928,903$1.28$4,704.00$1,188,995.84
3rd February 2020ACRS - Aclaris Therapeutics, Inc.10,800Exercise of derivative932,578$0.00
2nd March 2020ACRS - Aclaris Therapeutics, Inc.15,101Payment by withholding1,034,893$1.26$19,027.26$1,303,965.18
2nd March 2020ACRS - Aclaris Therapeutics, Inc.52,564Exercise of derivative1,049,994$0.00
2nd March 2020ACRS - Aclaris Therapeutics, Inc.27,623Payment by withholding997,430$1.26$34,804.98$1,256,761.80
2nd March 2020ACRS - Aclaris Therapeutics, Inc.96,150Exercise of derivative1,025,053$0.00
1st June 2020ACRS - Aclaris Therapeutics, Inc.20,976Payment by withholding1,086,931$1.32$27,688.32$1,434,748.92
1st June 2020ACRS - Aclaris Therapeutics, Inc.73,014Exercise of derivative1,107,907$0.00
1st September 2020ACRS - Aclaris Therapeutics, Inc.23,872Payment by withholding1,146,151$2.33$55,621.76$2,670,531.83
1st September 2020ACRS - Aclaris Therapeutics, Inc.83,092Exercise of derivative1,170,023$0.00